An observational study in Severe Obesity, sponsored by Uppsala University. Recruiting at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2023-12-26.
Sponsored by Uppsala University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Obesity, Morbid with a site in Sweden — 3 open to participants now, 5 under way, none of them phase 3. Obesity, Morbid · Sweden.
Among the 16 studies in Obesity, Morbid with a site in Sweden, this one is the only one that started in 2007, is one of 7 observational ones, and was the 11th registered.
941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.
Browse Obesity, Morbid studies →3 of the 16 studies in Obesity, Morbid with a site in Sweden are open now. Recruiting first, the newest first:
Umeå University · Sites in Sweden
Ages 18+
Göteborg University · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2007.
This study's planned enrollment of 25,000 is above the median of 80 across 311 observational studies indexed under Obesity, Morbid.
Median enrollment 140 across the 9 interventional studies, 1,400 across the 7 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 16 have an industry lead sponsor. The 9 most frequent:
Uppsala University is the lead sponsor of 390 studies on the registry; 86 are open to participants now.
Uppsala University has 2 studies filed under Obesity, Morbid — fewer than ten, so there is no comparison to draw.
2 of the studies in Obesity, Morbid with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02767505Göteborg UniversityBypass Equipoise Sleeve Trial (BEST) | 2026-12 |
| NCT03152617Göteborg UniversityBASUN - Risks for Malnutrition, Metabolic Bone Disease and Impaired Oral Health After Obesity Treatment | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies in Obesity, Morbid with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To evaluate effect on comorbid disease and weight loss in the long-term (>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.
Individuals with severe obesity frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss in the long-term (10 years) after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.
Individuals undergoing gastric bypass
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients undergoing gastric bypass
Procedure: Gastric bypass
Gastric bypass surgery, i.e., small gastric pouch and excluded main stomach
Change in comorbid conditions, as defined by use of pharmacological treatment
Remission of diabetes mellitus, hypertension, dyslipidemia, and depression as defined by use of pharmacological treatment, and sleep apnea as defined by use of CPAP. Data will be collected from SOReg.
Time frame: 10 years
Number of patients with pathological laboratory data (corresponding to the studied comorbid conditions)
Glucose, HbA1c, LDL, HDL, triglycerides, and blood pressure
Time frame: 10 years
Weight loss
Peroperative weight (in kg) minus current weight (in kg)
Time frame: 10 years
BMI loss
Peroperative BMI minus current BMI. Weight and height will be combined to report BMI in kg/m\^2.
Time frame: 10 years
Plan to share: No
No publications or documents are linked to this record.
Started May 2007 (actual). Primary completion is estimated for Jan 2025, 212 months after the start.
Of 138 non-industry observational studies under Obesity, Morbid, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 132. This study's planned 212 months is above that.
Counting every sponsor, half of 139 studies reached it within 46 months; a quarter within 16 and three quarters within 132.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.